AlphaYou
Overview
Smart money at a glance
Filings to Oct 7, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 7- Open
- $20.07
- 52-wk high
- $24.43
- High
- $20.12
- 52-wk low
- $10.65
- Low
- $19.44
- Prev close
- $20.04
- Mkt cap
- $5.67B
- Volume
- 4.02M
- P/S
- 1.8x
- P/B
- 1.6x
- Profit margin
- -9.7%
- Op margin
- +0.5%
- ROE
- -8.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about MMED filings
Are insiders buying or selling MiniMed Group, Inc. Common Stock (MMED) stock?
Neither. MiniMed Group, Inc. Common Stock (MMED) insiders filed no open-market purchases or sales in the 90 days to Oct 7, 2026, according to SEC Form 4 filings.
Which members of Congress have traded MMED recently?
None. No member of Congress disclosed a MMED trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this MMED smart-money data?
This summary uses filings available on Oct 7, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
How top traders are positioned
No tracked top-trader positions in MMED right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in $0.04 a share above what analysts expected.
Last report
Sep 8, 2026
Period ending
Jul 31, 2026
Adjusted EPS
$0.10 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 8, 2026 | $0.13 / $0.10Yahoo Finance | +$0.04 beat | Unavailable | Unavailable |
| Apr 30, 2026 | Jun 29, 2026 | -$0.60 / -$0.22Yahoo Finance | -$0.38 miss | Unavailable | Unavailable |
| Jan 31, 2026 | Apr 17, 2026 | $0.08 / $0.21Yahoo Finance | -63.75% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -9.7%
- Market cap
- $5.7B
Valuation
- P/S1.76
- P/B1.59
Quality
- Operating margin0.5%
- ROE-8.7%
- ROA1.7%
Growth
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace